Pharmaceutical Industry Reports Rivaroxaban market Clique para ler
  • Comentários

Pharmaceutical Industry Reports

Rivaroxaban market

Publicado no e em "Saúde & Fitness, Ciências", idioma — English. 8 páginas.
Rivaroxaban is a Non-Vitamin K Antagonist Oral Anticoagulants (NOAC) that is marketed as Xarelto. Anticoagulant medicines are potent therapeutic agents used in the prevention or treatment of serious illnesses and potentially life-threatening conditions associated with blood coagulation. Mais
Mostrar Tags

Outras publicação de "Pharmaceutical Industry Reports"

Ver todas as publicações